An SCN9A channelopathy causes congenital inability to experience pain
about
Progress in genetic studies of pain and analgesiaA gain-of-function mutation in TRPA1 causes familial episodic pain syndromeTranscriptional regulator PRDM12 is essential for human pain perceptionChannelopathiesDiscovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models.A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene.Pain as a channelopathyDistinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neuronsStructural determinants of drugs acting on the Nav1.8 channelDynorphin, stress, and depressionA Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivityTherapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug DiscoveryEmerging preclinical pharmacological targets for Parkinson's diseaseGenetic neurological channelopathies: molecular genetics and clinical phenotypes.Primary erythromelalgia: a reviewVoltage-gated sodium channels and cancer: is excitability their primary role?Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channelsCellular hyper-excitability caused by mutations that alter the activation process of voltage-gated sodium channelsThe perception and endogenous modulation of painStructure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activityδ-Conotoxin SuVIA suggests an evolutionary link between ancestral predator defence and the origin of fish-hunting behaviour in carnivorous cone snailsAnalysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV ( -TRTX-Hh2a)Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonistChanging channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitabilityA monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch reliefEndogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7Nav1.7 and other voltage-gated sodium channels as drug targets for pain reliefNeurobiology: a channel sets the gain on painA de novo gain-of-function mutation in SCN11A causes loss of pain perceptionPain genesGlobal Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to painModeling nociception in zebrafish: a way forward for unbiased analgesic discoveryMouse DRG Cell Line with Properties of NociceptorsInhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund's Adjuvant Models of PainInfantile Pain Episodes Associated with Novel Nav1.9 Mutations in Familial Episodic Pain Syndrome in Japanese FamiliesContinuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathySilencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injuryIn vivo regulation of NGF-mediated functions by Nedd4-2 ubiquitination of TrkASubtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release.Voltage-gated sodium channel in grasshopper mice defends against bark scorpion toxin
P2860
Q24289028-4997689C-C9CB-4A14-9EB5-86A46B9903EFQ24320280-3276D91B-4AA2-49FB-AFCC-3D5647167A5BQ24337786-0C492F73-7F77-4A3B-8A4A-C9CC983FDCBDQ24601791-B92E3B64-FD7B-4063-B2DC-281517AC143BQ24605644-F5FD78E2-3A85-43B7-94A4-42DA61483B00Q24620790-FAAAEF98-C648-47B7-AE41-4C5DF101D195Q24622323-0D7C21A8-A1D7-4642-949E-29692648CC06Q24632552-FF1D826C-6A3B-4A00-87DC-CAFC823B6D78Q24644825-520C3DF7-1C5A-4B4C-A249-875303952E5DQ24650168-9DB4E745-37BB-4598-A641-4D7D43827685Q24679655-934CB77A-4738-4D8D-A856-A342A54900E6Q26744730-CFC4D372-4958-4579-A3C2-100D705ADCE6Q26764724-55DBF66C-30C4-4F6F-A692-7393D35ADB23Q26777559-704A3B09-9D7E-4A97-8D0E-610D0B7E70F7Q26784432-8B345DBA-8EB2-4B13-A3FB-19DE504FBFB1Q26797387-F30FB811-EBF5-47C8-9D38-AE64598ADC83Q26800090-D71E4E27-31CA-4836-A875-F78FF1F7A4D4Q27008161-D2C66B56-41AE-4826-AE27-D538E1F3E37EQ27011310-1E84D987-979E-4EFD-93C3-EDB652F8A6DBQ27021886-979EA1BA-198A-4A1E-B09F-BD711D14203AQ27329762-4FD486F6-8550-480A-81D1-55A9BDB74DD2Q27678595-D7A56BE8-8195-4CA9-8936-793702FBCC60Q27703155-F5DAD8D2-406A-478F-A65B-FDE591E0A27EQ28081164-B9D961F5-3746-4C78-8AA3-00DBF8733043Q28240662-B29C6A82-9E03-4FCD-A787-DD74264081C9Q28270611-0AC44BA6-15AB-4BA2-A5F1-05684B3E6227Q28273870-744D8DF4-EA6B-4D0B-8E37-9A92B957CDC6Q28278802-AB9172E6-71E7-47FC-AD6F-BD8C787ED589Q28298515-5A6BCC7B-D339-42B3-9F00-84684A374291Q28473018-724ED86F-A71C-4993-A328-71B78EE8BECEQ28542818-2C31BBBF-A080-4EE0-941F-B0BEE260848EQ28543016-CF953A47-E98D-424D-B132-C87AB3D7FDB8Q28548026-17E36DA0-AA16-4DD8-90EE-16772714AC09Q28548202-F059DD81-F34F-4F3D-B03A-56F3BA837B25Q28552394-7F26178F-5DBB-498A-AE6F-5015A6330117Q28580927-F205054D-FE26-4BC5-BC68-37380F2C3CC9Q28583612-935C8574-5213-4816-83CB-40D0BD72ED2FQ28589735-69270BAB-C5CD-4668-8A36-491303C4AE8CQ28601095-0562B760-16B0-400B-80F3-4F8AA6CF8500Q28655574-FE0964B5-59FD-4050-830D-07A9D97B0C73
P2860
An SCN9A channelopathy causes congenital inability to experience pain
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
An SCN9A channelopathy causes congenital inability to experience pain
@ast
An SCN9A channelopathy causes congenital inability to experience pain
@en
An SCN9A channelopathy causes congenital inability to experience pain
@nl
type
label
An SCN9A channelopathy causes congenital inability to experience pain
@ast
An SCN9A channelopathy causes congenital inability to experience pain
@en
An SCN9A channelopathy causes congenital inability to experience pain
@nl
prefLabel
An SCN9A channelopathy causes congenital inability to experience pain
@ast
An SCN9A channelopathy causes congenital inability to experience pain
@en
An SCN9A channelopathy causes congenital inability to experience pain
@nl
P2093
P50
P3181
P356
P1433
P1476
An SCN9A channelopathy causes congenital inability to experience pain
@en
P2093
Adeline K Nicholas
C Geoffrey Woods
Duncan P McHale
Emma Roberts
Gemma Thornton
Gulshan Karbani
Henan Hamamy
Hussain Jafri
James J Cox
John N Wood
P2888
P3181
P356
10.1038/NATURE05413
P407
P577
2006-12-14T00:00:00Z
P6179
1035659631